Bhushan Akshikar will be replacing Sridhar Venkatesh, who is moving to a new senior role within GSK Group effective from the same date as well, said the pharma company. Bhushan Akshikar is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry. Prior to joining GSK, Bhushan spent 15 years with Janssen, Johnson & Johnson in various roles leading both specialty and primary care business units in local and regional positions living in India, S Korea and Belgium. GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the worlds leading research-based pharmaceutical and healthcare companies. The pharmaceutical firms consolidated net profit declined 1.5% to Rs 119.28 crore on a 3.7% rise in net sales to Rs 745.10 in Q1 FY23 over Q1 FY22. The scrip declined 0.07% to end at Rs 1,377.60 on the BSE. Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.